Treat Malignant Ascites Caused by Gastrointestinal or Ovarian Cancer With M701 Bispecific Antibody
Conditions: Malignant Ascites Interventions: Drug: M701; Drug: paracentesis Sponsors: Wuhan YZY Biopharma Co., Ltd. Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 19, 2024 Category: Research Source Type: clinical trials
Components of Metabolic Derangement and Paracentesis for Determination of Surgery in Preterm Neonates With Necrotizing Enterocolitis.
Condition: Necrotizing Enterocolitis Interventions: Procedure: Association of the components of metabolic derangement and paracentesis.; Procedure: Bell's criteria: pneumoperitoneum Sponsors: Gerardo Fernández Ortega; Instituto Materno Infantil del Estado de México; Instituto de Salud del Estado de México Terminated (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
Repurposing Atovaquone for the Treatment of Platinum-Resistant Ovarian Cancer
Conditions: Ovarian High Grade Serous Adenocarcinoma; Platinum-Resistant Ovarian Carcinoma Interventions: Drug: Atovaquone; Procedure: Biopsy; Procedure: Computed Tomography; Procedure: Paracentesis Sponsors: Emory University; National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 18, 2023 Category: Research Source Type: clinical trials
